Search Results - "Beer, Ambros J."

Refine Results
  1. 1
  2. 2

    PET/MR imaging in the detection and characterization of pulmonary lesions: technical and diagnostic evaluation in comparison to PET/CT by Rauscher, Isabel, Eiber, Matthias, Fürst, Sebastian, Souvatzoglou, Michael, Nekolla, Stephan G, Ziegler, Sibylle I, Rummeny, Ernst J, Schwaiger, Markus, Beer, Ambros J

    Published in Journal of Nuclear Medicine (01-05-2014)
    “…Fully integrated PET/MR imaging holds great promise as a novel hybrid imaging modality in oncology and might offer advantages to PET/CT in many instances,…”
    Get full text
    Journal Article
  3. 3

    Population-based model selection for an accurate estimation of time-integrated activity using non-linear mixed-effects modelling by Hardiansyah, Deni, Riana, Ade, Eiber, Matthias, Beer, Ambros J., Glatting, Gerhard

    Published in Zeitschrift für medizinische Physik (01-08-2024)
    “…Personalized treatment planning in Molecular Radiotherapy (MRT) with accurately determining the absorbed dose is highly desirable. The absorbed dose is…”
    Get full text
    Journal Article
  4. 4

    PET/CT Imaging of Integrin αvβ3 Expression in Human Carotid Atherosclerosis by Beer, Ambros J., MD, Pelisek, Jaroslav, PhD, Heider, Peter, MD, Saraste, Antti, MD, Reeps, Christian, MD, Metz, Stephan, MD, Seidl, Stefan, MD, Kessler, Horst, PhD, Wester, Hans-Jürgen, PhD, Eckstein, Hans Henning, MD, Schwaiger, Markus, MD

    Published in JACC. Cardiovascular imaging (01-02-2014)
    “…Objectives The goal of this study was to evaluate the feasibility of [18 F]Galacto-RGD positron emission tomography (PET)/computed tomography (CT) imaging of…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Single-time-point estimation of absorbed doses in PRRT using a non-linear mixed-effects model by Hardiansyah, Deni, Riana, Ade, Beer, Ambros J., Glatting, Gerhard

    Published in Zeitschrift für medizinische Physik (01-02-2023)
    “…Estimation of accurate time-integrated activity coefficients (TIACs) and radiation absorbed doses (ADs) is desirable for treatment planning in peptide-receptor…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Workflow and scan protocol considerations for integrated whole-body PET/MRI in oncology by Martinez-Möller, Axel, Eiber, Matthias, Nekolla, Stephan G, Souvatzoglou, Michael, Drzezga, Alexander, Ziegler, Sibylle, Rummeny, Ernst J, Schwaiger, Markus, Beer, Ambros J

    Published in Journal of Nuclear Medicine (01-09-2012)
    “…Integrated PET/MRI systems open exciting possibilities for clinical and research applications. However, compared with PET/CT, PET/MRI is a complex technique…”
    Get full text
    Journal Article
  9. 9

    Single-time-point dosimetry using model selection and nonlinear mixed-effects modelling: a proof of concept by Hardiansyah, Deni, Riana, Ade, Beer, Ambros J., Glatting, Gerhard

    Published in EJNMMI physics (10-02-2023)
    “…Purpose This project aims to develop and evaluate a method for accurately determining time-integrated activities (TIAs) in single-time-point (STP) dosimetry…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Radionuclide and hybrid imaging of recurrent prostate cancer by Beer, Ambros J, Dr, Eiber, Matthias, MD, Souvatzoglou, Michael, MD, Schwaiger, Markus, Prof, Krause, Bernd Joachim, Prof

    Published in The lancet oncology (01-02-2011)
    “…Summary Prostate cancer is one of the most common cancers in men, leading to substantial morbidity and mortality. After definitive therapy with surgery or…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Influence of sampling schedules on [177Lu]Lu-PSMA dosimetry by Rinscheid, Andreas, Kletting, Peter, Eiber, Matthias, Beer, Ambros J., Glatting, Gerhard

    Published in EJNMMI physics (17-06-2020)
    “…Background Individualized dosimetry is recommended for [ 177 Lu]Lu-PSMA radioligand therapy (RLT) which is resource-intensive and protocols are often not…”
    Get full text
    Journal Article
  15. 15
  16. 16

    A Physiologically Based Pharmacokinetic Model for In Vivo Alpha Particle Generators Targeting Neuroendocrine Tumors in Mice by Zaid, Nouran R R, Kletting, Peter, Winter, Gordon, Prasad, Vikas, Beer, Ambros J, Glatting, Gerhard

    Published in Pharmaceutics (10-12-2021)
    “…In vivo alpha particle generators have great potential for the treatment of neuroendocrine tumors in alpha-emitter-based peptide receptor radionuclide therapy…”
    Get full text
    Journal Article
  17. 17

    PET-MRI Fusion in Head-and-Neck Oncology: Current Status and Implications for Hybrid PET/MRI by Loeffelbein, Denys J., MD, DDS, Souvatzoglou, Michael, MD, Wankerl, Veronika, MD, Martinez-Möller, Axel, MD, Dinges, Julia, MD, Schwaiger, Markus, MD, Beer, Ambros J., MD

    Published in Journal of oral and maxillofacial surgery (01-02-2012)
    “…Purpose To review the current status and clinical effect of PET-MRI image fusion in the staging of head-and-neck cancer and to show its implications for…”
    Get full text
    Journal Article
  18. 18

    Comparison of PSMA-TO-1 and PSMA-617 labeled with gallium-68, lutetium-177 and actinium-225 by Meyer, Catherine, Prasad, Vikas, Stuparu, Andreea, Kletting, Peter, Glatting, Gerhard, Miksch, Jonathan, Solbach, Christoph, Lueckerath, Katharina, Nyiranshuti, Lea, Zhu, Shaojun, Czernin, Johannes, Beer, Ambros J., Slavik, Roger, Calais, Jeremie, Dahlbom, Magnus

    Published in EJNMMI research (01-10-2022)
    “…Background PSMA-TO-1 (“Tumor-Optimized-1”) is a novel PSMA ligand with longer circulation time than PSMA-617. We compared the biodistribution in subcutaneous…”
    Get full text
    Journal Article
  19. 19
  20. 20